Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036217 · ClinicalTrials.gov registry record
Screening Protocol for the Evaluation of Research Participants
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 55,000
- Enrollment target
NCT01036217 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 55,000 participants.
The verdict
NCT01036217 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 55,000 participants
- Enrollment target
Study Summary
Background: \- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening. Objectives: \- To identify, recruit, and screen participants for NIDA research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design: * Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. * The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff. * During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies. * No clinical care will be provided as part of screening.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55,000 participants |
| Start Date | 2006-05-17 |
| Est. Completion | 2010-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036217
The ClinicalTrials.gov registry entry for NCT01036217 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01036217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01036217 about?
NCT01036217 is a clinical study titled "Screening Protocol for the Evaluation of Research Participants". Background: \- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applican...
What is the current status of trial NCT01036217?
This trial is currently completed. The enrollment target is 55,000 participants. The study started on 2006-05-17. Estimated completion is 2010-06-17.
Who is sponsoring clinical trial NCT01036217?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.